N-Acetylcysteine in Patients With Sickle Cell Disease

NCT01849016 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: N-Acetylcysteine
DRUG: Placebo

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]